Cytokeratin 14 (LL002) Mouse
Cytokeratin 14 (LL002) Mouse
| Application | IHC |
| Clone | LL002 |
| Conjugué | Unconjugated |
| Conseil | |
| Couleur | |
| Hôte | Mouse |
| Immunogène | Synthetic peptide of 15 amino acid residues from the C-terminus of the human cytokeratin 14 |
| Isotype | IgG3 |
| Localisation | Cytoplasmic |
| Pathologie | Breast Cancer, Melanoma, Skin Cancer, Kidney, Urothelial Cancer |
| Predicted reactivity | |
| Purification | |
| Réactivité | Human, Rat |
| Spécificité | |
| Taille | |
| Tissus controles | Squamous Mucosa, Prostate, Breast, Tonsil, Salivary Gland, Skin, Cervix Carcinoma, Squamous Carcinoma |
Prêt à l'emploi
| Conditionnement | Référence | Fournisseur | Certification | Dilution | TDS | Quantité |
|---|---|---|---|---|---|---|
| 3 ml | BSB6219 |
|
IVD/CE | RTU |
|
|
| 15 ml | BSB6221 |
|
IVD/CE | RTU |
|
|
| 7 ml | BSB6220 |
|
IVD/CE | RTU |
|
|
| 3 ml | 2-CY181-10 |
|
RUO | RTU | ||
| 7 ml | 2-CY181-13 |
|
RUO | RTU |
Control Slides
| Conditionnement | Référence | Fournisseur | Certification | Dilution | TDS | Quantité |
|---|---|---|---|---|---|---|
| 5 slides | BSB6225 |
|
IVD/CE |
|
||
| 5 slides | BSB9134-CS |
|
IVD/CE |
|
Concentré
| Conditionnement | Référence | Fournisseur | Certification | Dilution | TDS | Quantité |
|---|---|---|---|---|---|---|
| 20 µg | 601-2167 |
|
RUO | |||
| 0,1 ml | BSB6222 |
|
IVD/CE | 1/50 - 1/200 |
|
|
| 1 ml | BSB6224 |
|
IVD/CE | 1/50 - 1/200 |
|
|
| 0,5 ml | BSB6223 |
|
IVD/CE | 1/50 - 1/200 |
|
|
| 1 ml | 1-CY181-07 |
|
RUO | |||
| 0,1 ml | 1-CY181-02 |
|
RUO | |||
| 0,5 ml | 1-CY181-05 |
|
RUO |